We have explored further the molecular requirements of PARP9/DTX3L and PARP14 mediated survival using head and neck squamous cell carcinoma (HNSCC) and HeLa cell lines, which have increased PARP9/DTX3L and PARP14 expression. The gene discussed is DTX3L; the disease is head and neck squamous cell carcinoma.